Minerva Neurosciences to Host In-Person KOL Event on Roluperidone
Minerva Neurosciences plans an in-person key opinion leader event to discuss roluperidone for negative symptoms of schizophrenia.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.